Ravi Salgia to Heterozygote
This is a "connection" page, showing publications Ravi Salgia has written about Heterozygote.
Connection Strength
0.026
-
Initial clinical sensitivity and acquired resistance to MET inhibition in MET-mutated papillary renal cell carcinoma. J Clin Oncol. 2013 Jun 01; 31(16):e254-8.
Score: 0.026